HAGENS
Beyond's analysis on HAGENS
Recent news mentioning HAGENS
- — Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
- — HDB ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages HDFC Bank Limited (NYSE: HDB) Investors to Contact its Legal Team Regarding Securities Fraud Class Action Lawsuit
- — BABA ALERT: Alibaba Group Holding Limited (NYSE: BABA) Investors Urged to Contact Hagens Berman
- — Pentair plc (PNR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 2, 2026 Lead Plaintiff Deadline
- — Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
- — Wix.com (WIX) Faces Securities Class Action Amid Scrutiny Over Vibe Coding Transition, Competitive and Financial Positioning - Hagens Berman
- — Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
- — AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action
- — HDFC Bank Limited (HDB) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
- — Wix.com Ltd. (WIX) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 22, 2026 Lead Plaintiff Deadline
- — CAPR Stock Alert: Capricor Therapeutics, Inc. Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman
- — REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Fraud Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
Appears alongside
Browse the full archive →